Lunai Bioworks Inc. financial data

Symbol
LNAI on Nasdaq
Location
Suite 906 Los Angeles, CA
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7% % -21%
Debt-to-equity 80% % 187%
Return On Equity -67% % 53%
Return On Assets -214% % -126%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 231,802,470 shares 48%
Common Stock, Shares, Outstanding 23,180,277 shares -86%
Entity Public Float $111,903,627 USD 96%
Common Stock, Value, Issued $2,318 USD -86%
Weighted Average Number of Shares Outstanding, Basic 22,520,245 shares 41%
Weighted Average Number of Shares Outstanding, Diluted 22,520,245 shares 41%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $24,407 USD -94%
General and Administrative Expense $14,989,315 USD -31%
Operating Income (Loss) $138,935,808 USD -10%
Nonoperating Income (Expense) $7,959,376 USD 203%
Net Income (Loss) Attributable to Parent $130,976,432 USD -6.1%
Earnings Per Share, Basic 1 USD/shares
Earnings Per Share, Diluted 1 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $624,808 USD 183%
Accounts Receivable, after Allowance for Credit Loss, Current $964,389 USD
Assets, Current $800,360 USD -59%
Property, Plant and Equipment, Net $12,465 USD -97%
Operating Lease, Right-of-Use Asset $687,371 USD -46%
Goodwill $5,963,000 USD -95%
Other Assets, Noncurrent $6,147,838 USD -95%
Assets $6,960,663 USD -94%
Accounts Payable, Current $167,259 USD
Accrued Liabilities, Current $4,868,686 USD -9.2%
Liabilities, Current $19,722,474 USD -14%
Operating Lease, Liability, Noncurrent $278,963 USD -61%
Other Liabilities, Noncurrent $271,643 USD 17%
Liabilities $20,001,437 USD -16%
Accumulated Other Comprehensive Income (Loss), Net of Tax $128,161 USD -102%
Retained Earnings (Accumulated Deficit) $507,643,549 USD -35%
Stockholders' Equity Attributable to Parent $13,040,774 USD -113%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $88,386,851 USD -34%
Liabilities and Equity $6,960,663 USD -94%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,349,110 USD 33%
Net Cash Provided by (Used in) Financing Activities $1,343,357 USD -34%
Net Cash Provided by (Used in) Investing Activities $544,700 USD
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 23,180,277 shares -86%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $532,108 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $624,808 USD 183%
Interest Paid, Excluding Capitalized Interest, Operating Activities $8,559 USD
Deferred Tax Assets, Valuation Allowance $83,680,863 USD -51%
Depreciation $113,563 USD 5.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $137,401,808 USD -17%
Lessee, Operating Lease, Liability, to be Paid $737,593 USD -45%
Property, Plant and Equipment, Gross $1,070,023 USD 0.9%
Operating Lease, Liability, Current $277,775 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year Two $358,326 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year One $363,999 USD -34%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $41,353 USD -55%
Lessee, Operating Lease, Liability, to be Paid, Year Three $334,788 USD 28%
Deferred Tax Assets, Operating Loss Carryforwards $76,296,814 USD -49%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $309,491 USD
Operating Lease, Payments $108,441 USD 9.6%
Additional Paid in Capital $494,728,618 USD 5.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $8,296 USD 34%
Depreciation, Depletion and Amortization $138,232 USD 8.9%
Interest Expense $303,802 USD 148%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%